Chengdu Huasun Group Inc Ltd (000790) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chengdu Huasun Group Inc Ltd (000790) has a cash flow conversion efficiency ratio of -0.142x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-134.75 Million ≈ $-19.72 Million USD) by net assets (CN¥949.82 Million ≈ $138.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Chengdu Huasun Group Inc Ltd net asset quality index to measure how much of total assets are equity-financed.
Chengdu Huasun Group Inc Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Chengdu Huasun Group Inc Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000790 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Chengdu Huasun Group Inc Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chengdu Huasun Group Inc Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen King Brother Electronics Technology Co.Ltd.
SHE:301041
|
N/A |
|
Hangzhou Zongheng Commun
SHG:603602
|
-0.122x |
|
Mobiltel Iletisim Hizmetleri Sanayi ve Ticaret AS
IS:MOBTL
|
-0.014x |
|
Muang Thai Insurance Public Company Limited
BK:MTI
|
0.031x |
|
The Metals Royalty Company Inc. Common Stock
NASDAQ:TMCR
|
-0.095x |
|
Balmer Lawrie & Company Limited
NSE:BALMLAWRIE
|
-0.035x |
|
Beijing AriTime Intelligent Control Co Ltd
SHG:600560
|
-0.046x |
|
BlackRock California Municipal Income Closed Fund
NYSE:BFZ
|
-0.060x |
Annual Cash Flow Conversion Efficiency for Chengdu Huasun Group Inc Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Chengdu Huasun Group Inc Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Chengdu Huasun Group Inc Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.07 Billion ≈ $156.28 Million |
CN¥64.28 Million ≈ $9.41 Million |
0.060x | +36.64% |
| 2023-12-31 | CN¥1.08 Billion ≈ $157.51 Million |
CN¥47.41 Million ≈ $6.94 Million |
0.044x | -71.59% |
| 2022-12-31 | CN¥1.01 Billion ≈ $147.14 Million |
CN¥155.89 Million ≈ $22.81 Million |
0.155x | +373.47% |
| 2021-12-31 | CN¥981.44 Million ≈ $143.61 Million |
CN¥-55.64 Million ≈ $-8.14 Million |
-0.057x | -483.30% |
| 2020-12-31 | CN¥912.45 Million ≈ $133.52 Million |
CN¥13.50 Million ≈ $1.97 Million |
0.015x | -79.97% |
| 2019-12-31 | CN¥880.71 Million ≈ $128.88 Million |
CN¥65.03 Million ≈ $9.52 Million |
0.074x | -42.74% |
| 2018-12-31 | CN¥835.55 Million ≈ $122.27 Million |
CN¥107.74 Million ≈ $15.77 Million |
0.129x | +455.61% |
| 2017-12-31 | CN¥838.86 Million ≈ $122.75 Million |
CN¥-30.42 Million ≈ $-4.45 Million |
-0.036x | -146.80% |
| 2016-12-31 | CN¥665.85 Million ≈ $97.43 Million |
CN¥51.59 Million ≈ $7.55 Million |
0.077x | +174.68% |
| 2015-12-31 | CN¥583.35 Million ≈ $85.36 Million |
CN¥-60.53 Million ≈ $-8.86 Million |
-0.104x | -256.97% |
| 2014-12-31 | CN¥632.30 Million ≈ $92.53 Million |
CN¥-18.38 Million ≈ $-2.69 Million |
-0.029x | -148.83% |
| 2013-12-31 | CN¥585.45 Million ≈ $85.67 Million |
CN¥34.85 Million ≈ $5.10 Million |
0.060x | +169.98% |
| 2012-12-31 | CN¥545.88 Million ≈ $79.88 Million |
CN¥-46.44 Million ≈ $-6.80 Million |
-0.085x | -169.87% |
| 2011-12-31 | CN¥492.53 Million ≈ $72.07 Million |
CN¥59.97 Million ≈ $8.77 Million |
0.122x | -51.64% |
| 2010-12-31 | CN¥460.83 Million ≈ $67.43 Million |
CN¥116.01 Million ≈ $16.98 Million |
0.252x | +242.21% |
| 2009-12-31 | CN¥402.43 Million ≈ $58.89 Million |
CN¥29.60 Million ≈ $4.33 Million |
0.074x | +153.97% |
| 2008-12-31 | CN¥414.42 Million ≈ $60.64 Million |
CN¥12.00 Million ≈ $1.76 Million |
0.029x | +469.78% |
| 2007-12-31 | CN¥414.55 Million ≈ $60.66 Million |
CN¥2.11 Million ≈ $308.37K |
0.005x | -88.28% |
| 2006-12-31 | CN¥427.78 Million ≈ $62.60 Million |
CN¥18.56 Million ≈ $2.72 Million |
0.043x | -17.81% |
| 2005-12-31 | CN¥423.41 Million ≈ $61.96 Million |
CN¥22.35 Million ≈ $3.27 Million |
0.053x | +84.70% |
| 2004-12-31 | CN¥434.58 Million ≈ $63.59 Million |
CN¥12.42 Million ≈ $1.82 Million |
0.029x | -67.09% |
| 2003-12-31 | CN¥417.14 Million ≈ $61.04 Million |
CN¥36.23 Million ≈ $5.30 Million |
0.087x | +320.05% |
| 2002-12-31 | CN¥407.64 Million ≈ $59.65 Million |
CN¥8.43 Million ≈ $1.23 Million |
0.021x | -64.00% |
| 2001-12-31 | CN¥422.61 Million ≈ $61.84 Million |
CN¥24.27 Million ≈ $3.55 Million |
0.057x | -1.18% |
| 2000-12-31 | CN¥271.28 Million ≈ $39.70 Million |
CN¥15.77 Million ≈ $2.31 Million |
0.058x | -0.08% |
| 1999-12-31 | CN¥236.56 Million ≈ $34.62 Million |
CN¥13.76 Million ≈ $2.01 Million |
0.058x | -77.02% |
| 1998-12-31 | CN¥220.50 Million ≈ $32.27 Million |
CN¥55.81 Million ≈ $8.17 Million |
0.253x | -- |
About Chengdu Huasun Group Inc Ltd
Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of … Read more